CorMedix Inc (CRMD) is a Healthcare · Biotechnology company listed on NASDAQ. Price $7.77 (-0.26%), Market cap $0.59B, P/E ratio 3.48, 52-week low–high $6.25 ~ $16.56.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.
Financial statements, price targets, institutional (13F) holdings and related news for CorMedix Inc are updated in real time on BlackAll Trade.
CorMedix Inc trades at $7.77 (-0.26%). Real-time quotes and charts are available on BlackAll Trade.
CorMedix Inc has a market cap of about $0.59B. Its P/E ratio is 3.48.
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate